Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts

Abraham, 2008, Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?, Rheumatology (Oxford, England), 47, v8, 10.1093/rheumatology/ken278

Biernacka, 2011, TGF-beta signaling in fibrosis, Growth Factors (Chur, Switzerland), 29, 196, 10.3109/08977194.2011.595714

Canto, 2010, AMP-activated protein kinase and its downstream transcriptional pathways, Cell. Mol. Life Sci., 67, 3407, 10.1007/s00018-010-0454-z

Chen, 2009, CTGF and chronic kidney fibrosis, Front. Biosci. (Schol. Ed.), 1, 132, 10.2741/s13

Crean, 2001, Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease, Expert Opin. Ther. Targets, 5, 519, 10.1517/14728222.5.4.519

Eddy, 1996, Molecular insights into renal interstitial fibrosis, J. Am. Soc. Nephrol., 7, 2495, 10.1681/ASN.V7122495

Farris, 2012, Renal interstitial fibrosis: mechanisms and evaluation, Curr. Opin. Nephrol. Hypertens., 21, 289, 10.1097/MNH.0b013e3283521cfa

Flanders, 2004, Smad3 as a mediator of the fibrotic response, Int. J. Exp. Pathol., 85, 47, 10.1111/j.0959-9673.2004.00377.x

Hall-Glenn, 2011, Roles for CCN2 in normal physiological processes, Cell. Mol. Life Sci., 68, 3209, 10.1007/s00018-011-0782-7

Hardie, 2011, AMP-activated protein kinase—an energy sensor that regulates all aspects of cell function, Genes Dev., 25, 1895, 10.1101/gad.17420111

Hardie, 2006, AMP-activated protein kinase-development of the energy sensor concept, J. Physiol., 574, 7, 10.1113/jphysiol.2006.108944

Hills, 2011, The role of TGF-beta and epithelial- to mesenchymal transition in diabetic nephropathy, Cytokine Growth Factor Rev., 22, 131

Huang, 2012, Regulation of hepatic stellate cells by connective tissue growth factor, Front. Biosci. (Landmark Ed.), 17, 2495, 10.2741/4067

Islam, 2014, TGF-beta1 induces EMT reprogramming of porcine bladder urothelial cells into collagen producing fibroblasts-like cells in a Smad2/Smad3-dependent manner, J. Cell Commun. Signal., 8, 39, 10.1007/s12079-013-0216-4

Jagadeesan, 2007, Transforming growth factor beta (TGFbeta) and keloid disease, Int. J. Surg., 5, 278, 10.1016/j.ijsu.2006.04.007

Kim, 2013, Targeting the AMP-activated protein kinase for cancer prevention and therapy, Front. Oncol., 3, 10.3389/fonc.2013.00175

Koo, 2006, Renal interstitial fibrosis and angiotensin inhibition, Electrolyte Blood Press, 4, 35, 10.5049/EBP.2006.4.1.35

Lan, 2011, Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation, Int. J. Biol. Sci., 7, 1056, 10.7150/ijbs.7.1056

Lan, 2012, TGF-beta/Smad signaling in kidney disease, Semin. Nephrol., 32, 236, 10.1016/j.semnephrol.2012.04.002

Lee, 2013, AMP-activated protein kinase inhibits TGF-beta-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial–mesenchymal transition, Am. J. Physiol. Ren. Physiol., 304, F686, 10.1152/ajprenal.00148.2012

Lee, 2007, A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy, Am. J. Physiol. Ren. Physiol., 292, F617, 10.1152/ajprenal.00278.2006

Lim, 2012, AMP-activated protein kinase inhibits TGF-beta-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300, J. Cell. Physiol., 227, 1081, 10.1002/jcp.22824

Liu, 2013, Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice, PLoS One, 8, e53573, 10.1371/journal.pone.0053573

Liu, 2010, Regulation of TGF-beta signalling by protein phosphatases, Biochem. J., 430, 191, 10.1042/BJ20100427

Lonnemann, 1995, Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts, Kidney Int., 47, 837, 10.1038/ki.1995.126

Meng, 2013, Role of the TGF-beta/BMP-7/Smad pathways in renal diseases, Clin. Sci. (Lond.), 124, 243, 10.1042/CS20120252

Mihaylova, 2011, The AMP-activated protein kinase (AMPK) signaling pathway coordinates cell growth, autophagy, & metabolism, Nat. Cell Biol., 13, 1016, 10.1038/ncb2329

Mishra, 2008, AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation, J. Biol. Chem., 283, 10461, 10.1074/jbc.M800902200

Mun, 2014, Simvastatin inhibits transforming growth factor-beta1-induced expression of type I collagen, CTGF, and alpha-SMA in keloid fibroblasts, Wound Repair Regen., 22, 125, 10.1111/wrr.12136

Pawlyk, 2014, Metformin pharmacogenomics: current status and future directions, Diabetes, 63, 2590, 10.2337/db13-1367

Peairs, 2009, Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells, Clin. Exp. Immunol., 156, 542, 10.1111/j.1365-2249.2009.03924.x

Phanish, 2005, TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling, Nephron Exp. Nephrol., 100, e156, 10.1159/000085445

Ratner, 1997, Current view on mediators role in pathogenesis of renal interstitial fibrosis (review), Ter. Arkh., 69, 87

Samarakoon, 2013, TGF-beta signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities, Cell. Signal., 25, 264, 10.1016/j.cellsig.2012.10.003

Satriano, 2013, Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease, Am. J. Physiol. Ren. Physiol., 305, F727, 10.1152/ajprenal.00293.2013

Shaw, 2009, LKB1 and AMPK control of mTOR signalling and growth, Acta Physiol. (Oxf.), 196, 65, 10.1111/j.1748-1716.2009.01972.x

Su, 2002, Progress in the study of CCN family, Di 1 Jun Yi Da Xue Xue Bao, 22, 179

Takiar, 2011, Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis, Proc. Natl. Acad. Sci. U. S. A., 108, 2462, 10.1073/pnas.1011498108

Viollet, 2010, AMPK inhibition in health and disease, Crit. Rev. Biochem. Mol. Biol., 45, 276, 10.3109/10409238.2010.488215

Viollet, 2009, Targeting the AMPK pathway for the treatment of type 2 diabetes, Front. Biosci. (Landmark Ed.), 14, 3380, 10.2741/3460

Wang, 2005, Transforming growth factor-beta and Smad signalling in kidney diseases, Nephrology (Carlton, Vic.), 10, 48, 10.1111/j.1440-1797.2005.00334.x

Xu, 2012, Post-translational regulation of TGF-beta receptor and Smad signaling, FEBS Lett., 586, 1871, 10.1016/j.febslet.2012.05.010